Evidence map›Paper›PMID 41363756›Full record

ArticleGigaScience2025

A sulfatide-centered ultra-high-resolution magnetic resonance MALDI imaging benchmark dataset for MS1-based lipid annotation tools.

Lars Gruber, Stefan Schmidt, Thomas Enzlein, Carsten Hopf

Abstract read
In one paragraph

Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lars GruberCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, 68165 Mannheim, Germany.ORCID 0009-0009-9955-1550
Stefan SchmidtCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, 68165 Mannheim, Germany.ORCID 0000-0003-2896-3290
Thomas EnzleinCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, 68165 Mannheim, Germany.ORCID 0000-0003-1789-4090
Carsten HopfCeMOS Research and Transfer Center, Mass Spectrometry and Optical Spectroscopy, Technische Hochschule Mannheim, 68165 Mannheim, Germany.ORCID 0000-0003-0802-6451

Funding

Bundesministerium für Bildung und Forschung 12FH8I05IABundesministerium für Bildung und Forschung 13FH8I09IADFG 262133997DFG 497984836DFG INST874/9-1
6 · The paper itself

Abstract

backgroundSpatial omics techniques are indispensable for studying complex biological systems and for the discovery of spatial biomarkers. While several current matrix-assisted laser desorption/ionization mass spectrometry imaging (MSI) instruments are capable of localizing numerous metabolites at high spatial and spectral resolution, most MSI data are acquired at the MS1 level only. Assigning molecular identities based on MS1 data presents significant analytical and computational challenges, as the inherent limitations of MS1 data preclude confident annotations beyond the sum formula level.

resultsTo enable future advancements of computational lipid annotation tools, well-characterized benchmark-or ground-truth-datasets are crucial, which exceed the scope of synthetic data or data derived from mimetic tissue models. To this end, we provide 2 sulfatide-centered, biology-driven magnetic resonance MSI (MR-MSI) datasets at different mass resolving powers that characterize lipids in a mouse model of human metachromatic dystrophy. These data include an ultra-high-resolution (R ∼1,230,000) quantum cascade laser mid-infrared imaging-guided MR-MSI dataset that enables isotopic fine structure analysis and therefore enhances the level of confidence substantially. To highlight the usefulness of the data, we compared 118 manual sulfatide annotations with the number of decoy database-controlled sulfatide annotations performed in Metaspace (67 at a false discovery rate <10%).

conclusionsOverall, our datasets can be used to benchmark annotation algorithms, validate spatial biomarker discovery pipelines, and serve as a reference for future studies that explore sulfatide metabolism and its spatial regulation.

Indexed as

LipidsMagnetic Resonance ImagingSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSulfoglycosphingolipidsAnimalsDisease Models, AnimalHumansLeukodystrophy, MetachromaticMiceLipidsSulfoglycosphingolipidsisotope fine structurelipidomicsMALDI imagingMALDI mass spectrometrymass spectrometry imagingmetabolite annotation toolsmetabolomicsmid-infrared imagingMRMS

Identifiers

PMID41363756
PMCPMC12766628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.